INVO Fertility (IVF) Long-Term Deferred Tax (2019 - 2020)
INVO Fertility (IVF) posted quarterly Long-Term Deferred Tax of $468.0 for Q4 2020, up 8.08% year-over-year from $433.0 in Q1 2020, and up 8.08% quarter-over-quarter from $433.0 in Q4 2019.
INVO Fertility (IVF) Long-Term Deferred Tax (2019 - 2020) Analysis & Trends
INVO Fertility (IVF) has reported Long-Term Deferred Tax for 2 consecutive years, with $468.0 the latest figure, recorded in Q4 2020.
- In Q4 2020, Long-Term Deferred Tax rose 8.08% year-over-year to $468.0; the TTM figure through Dec 2020 stood at $468.0 (up 8.08% YoY), while the FY2020 annual figure was $468.0, up 8.08% from the prior year.
- Long-Term Deferred Tax grew to $468.0 in Q4 2020 per IVF's latest filing, from $433.0 in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $468.0 in Q4 2020 and bottomed at $433.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn |
| 10 | INVO Fertility | 2.53 Mn | 2.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 468.00 |
| Dec 31, 2019 | 433.00 |